source
- Drug repurposing: Stakeholders say FDA should act within its authority, avoid disincentivesPatient and healthcare industry stakeholders told the US Food and Drug Administration (FDA) that while there are significant opportunities to repurpose existing drugs, the agency should ensure any…raps · 15d ago↗ source
- Nobel Laureate Jennifer Doudna enters AI protein design arenaJennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene-editing, is dipping her toes into a new, buzzy field: AI-powered pro…Fierce Biotech · 15d ago↗ source
- Why early de-risking is redefining the path to INDLonza explains why early de-risking has become a strategic imperative for biotech teams working to reach IND with confidence.